Invivyd, Inc. (IVVD)
0.9645
+0.06
(+7.15%)
USD |
NASDAQ |
Aug 28, 16:00
0.9825
+0.02
(+1.87%)
Pre-Market: 09:02
Invivyd Debt to Equity Ratio : 0.0463 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0463 |
| March 31, 2026 | 0.0425 |
| December 31, 2025 | 0.0103 |
| September 30, 2025 | 0.0288 |
| June 30, 2025 | 0.0693 |
| March 31, 2025 | 0.0165 |
| December 31, 2024 | 0.0193 |
| September 30, 2024 | 0.0196 |
| June 30, 2024 | 0.0048 |
| March 31, 2024 | 0.0099 |
| December 31, 2023 | 0.0122 |
| September 30, 2023 | 0.0104 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0105 |
| March 31, 2023 | 0.0102 |
| December 31, 2022 | 0.0105 |
| September 30, 2022 | 0.004 |
| June 30, 2022 | 0.0069 |
| March 31, 2022 | 0.0036 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 218.88M |
| Total Liabilities (Quarterly) | 37.80M |
| Shareholders Equity (Quarterly) | 181.08M |
| Current Ratio | 5.869 |
| Net Debt Paydown Yield | -0.58% |